Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended December 31, 2025.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has submitted a confirmation certificate to BSE as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA), for the quarter ended December 31, 2025. This is a routine compliance filing confirming that the RTA has properly handled the dematerialisation and rematerialisation requests of the company's shareholders during the quarter. The letter, signed by Company Secretary Gurpreet Kaur, was dated January 14, 2026, and was sent to BSE's Department of Corporate Services at its usual Mumbai address. There are no financial numbers, transactions, or business developments disclosed in this filing.
This is a standard procedural compliance filing with no bearing on the company's financials, operations, or stock price. Shareholders do not need to take any action; it simply confirms the RTA's handling of share transfer activities during the October–December 2025 quarter.